Flurazepam Hydrochloride Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Flurazepam Hydrochloride Capsule (capsule) from Chartwell Molecular Holdings LLC with status Current. The shortage was first posted on 08/03/2022.
Shortage Details
- Status
- Current
- Company
- Chartwell Molecular Holdings LLC
- Package NDC
- 62135-737-90
- Dosage Form
- Capsule
- Presentation
- Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-90)
- Initial Posting
- 08/03/2022
- Revised Date